Literature DB >> 31548399

SerpinB1 controls encephalitogenic T helper cells in neuroinflammation.

Lifei Hou1,2, Deepak A Rao3,4, Koichi Yuki5,6, Jessica Cooley7, Lauren A Henderson2,8, A Helena Jonsson3,4, Dion Kaiserman9, Mark P Gorman2,10, Peter A Nigrovic3,4,8, Phillip I Bird9, Burkhard Becher11, Eileen Remold-O'Donnell1,2,12.   

Abstract

SerpinB1, a protease inhibitor and neutrophil survival factor, was recently linked with IL-17-expressing T cells. Here, we show that serpinB1 (Sb1) is dramatically induced in a subset of effector CD4 cells in experimental autoimmune encephalomyelitis (EAE). Despite normal T cell priming, Sb1 -/- mice are resistant to EAE with a paucity of T helper (TH) cells that produce two or more of the cytokines, IFNγ, GM-CSF, and IL-17. These multiple cytokine-producing CD4 cells proliferate extremely rapidly; highly express the cytolytic granule proteins perforin-A, granzyme C (GzmC), and GzmA and surface receptors IL-23R, IL-7Rα, and IL-1R1; and can be identified by the surface marker CXCR6. In Sb1 -/- mice, CXCR6+ TH cells are generated but fail to expand due to enhanced granule protease-mediated mitochondrial damage leading to suicidal cell death. Finally, anti-CXCR6 antibody treatment, like Sb1 deletion, dramatically reverts EAE, strongly indicating that the CXCR6+ T cells are the drivers of encephalitis.

Entities:  

Keywords:  autoimmune; inflammatory arthritis; multiple sclerosis; pathogenic T helper cells; serpins

Year:  2019        PMID: 31548399      PMCID: PMC6789640          DOI: 10.1073/pnas.1905762116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  61 in total

1.  C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE.

Authors:  Andrea Reboldi; Caroline Coisne; Dirk Baumjohann; Federica Benvenuto; Denise Bottinelli; Sergio Lira; Antonio Uccelli; Antonio Lanzavecchia; Britta Engelhardt; Federica Sallusto
Journal:  Nat Immunol       Date:  2009-03-22       Impact factor: 25.606

Review 2.  Lysosomal membrane permeabilization in cell death.

Authors:  P Boya; G Kroemer
Journal:  Oncogene       Date:  2008-10-27       Impact factor: 9.867

3.  The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites.

Authors:  J Cooley; T K Takayama; S D Shapiro; N M Schechter; E Remold-O'Donnell
Journal:  Biochemistry       Date:  2001-12-25       Impact factor: 3.162

4.  A pro-survival role for the intracellular granzyme B inhibitor Serpinb9 in natural killer cells during poxvirus infection.

Authors:  Matthew S Mangan; Carolina R Melo-Silva; Jennii Luu; Catherina H Bird; Aulikki Koskinen; Alexandra Rizzitelli; Monica Prakash; Katrina L Scarff; Arno Müllbacher; Matthias Regner; Phillip I Bird
Journal:  Immunol Cell Biol       Date:  2017-08-15       Impact factor: 5.126

5.  Cell death induced by granzyme C.

Authors:  Hillary Johnson; Luca Scorrano; Stanley J Korsmeyer; Timothy J Ley
Journal:  Blood       Date:  2002-12-19       Impact factor: 22.113

6.  Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.

Authors:  Hania Kebir; Igal Ifergan; Jorge Ivan Alvarez; Monique Bernard; Josée Poirier; Nathalie Arbour; Pierre Duquette; Alexandre Prat
Journal:  Ann Neurol       Date:  2009-09       Impact factor: 10.422

7.  Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway.

Authors:  C H Bird; V R Sutton; J Sun; C E Hirst; A Novak; S Kumar; J A Trapani; P I Bird
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

8.  Fate mapping of IL-17-producing T cells in inflammatory responses.

Authors:  Keiji Hirota; João H Duarte; Marc Veldhoen; Eve Hornsby; Ying Li; Daniel J Cua; Helena Ahlfors; Christoph Wilhelm; Mauro Tolaini; Ursula Menzel; Anna Garefalaki; Alexandre J Potocnik; Brigitta Stockinger
Journal:  Nat Immunol       Date:  2011-01-30       Impact factor: 25.606

9.  Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis.

Authors:  J L McQualter; R Darwiche; C Ewing; M Onuki; T W Kay; J A Hamilton; H H Reid; C C Bernard
Journal:  J Exp Med       Date:  2001-10-01       Impact factor: 14.307

10.  Induction and molecular signature of pathogenic TH17 cells.

Authors:  Youjin Lee; Amit Awasthi; Nir Yosef; Francisco J Quintana; Sheng Xiao; Anneli Peters; Chuan Wu; Markus Kleinewietfeld; Sharon Kunder; David A Hafler; Raymond A Sobel; Aviv Regev; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2012-09-09       Impact factor: 25.606

View more
  11 in total

Review 1.  Neuroinflammation: Extinguishing a blaze of T cells.

Authors:  Nail Benallegue; Hania Kebir; Jorge I Alvarez
Journal:  Immunol Rev       Date:  2022-07-31       Impact factor: 10.983

2.  Transcription Factor RUNX3 Mediates Plasticity of ThGM Cells Toward Th1 Phenotype.

Authors:  Javad Rasouli; Giacomo Casella; Weifeng Zhang; Dan Xiao; Gaurav Kumar; Paolo Fortina; Guang-Xian Zhang; Bogoljub Ciric; Abdolmohamad Rostami
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

3.  Assessing the Role of Long Noncoding RNA in Nucleus Accumbens in Subjects With Alcohol Dependence.

Authors:  John Drake; Gowon O McMichael; Eric Sean Vornholt; Kellen Cresswell; Vernell Williamson; Chris Chatzinakos; Mohammed Mamdani; Siddharth Hariharan; Kenneth S Kendler; Gursharan Kalsi; Brien P Riley; Mikhail Dozmorov; Michael F Miles; Silviu-Alin Bacanu; Vladimir I Vladimirov
Journal:  Alcohol Clin Exp Res       Date:  2020-11-27       Impact factor: 3.455

4.  CCR6 and CXCR6 Identify the Th17 Cells With Cytotoxicity in Experimental Autoimmune Encephalomyelitis.

Authors:  Lifei Hou; Koichi Yuki
Journal:  Front Immunol       Date:  2022-02-01       Impact factor: 7.561

5.  CXCR6 is required for antitumor efficacy of intratumoral CD8+ T cell.

Authors:  Binglin Wang; Yi Wang; Xiaofan Sun; Guoliang Deng; Wei Huang; Xingxin Wu; Yanghong Gu; Zhigang Tian; Zhimin Fan; Qiang Xu; Hongqi Chen; Yang Sun
Journal:  J Immunother Cancer       Date:  2021-08       Impact factor: 13.751

Review 6.  Chemokine-Driven Migration of Pro-Inflammatory CD4+ T Cells in CNS Autoimmune Disease.

Authors:  Aaron H S Heng; Caleb W Han; Caitlin Abbott; Shaun R McColl; Iain Comerford
Journal:  Front Immunol       Date:  2022-02-16       Impact factor: 7.561

7.  CXCR6-based immunotherapy in autoimmune, cancer and inflammatory infliction.

Authors:  Tingting Li; Jie Pan; Hongqi Chen; Yongliang Fang; Yang Sun
Journal:  Acta Pharm Sin B       Date:  2022-03-21       Impact factor: 14.903

8.  MW‑9, a chalcones derivative bearing heterocyclic moieties, attenuates experimental autoimmune encephalomyelitis via suppressing pathogenic TH17 cells.

Authors:  Bei Liu; Zewei Mao; Na Yin; Qianlan Gu; Qianlan Gu; Yan Qi; Xiaosi Li; Haihao Yang; Zhao Wu; Nanting Zou; Sai Ying; Chunping Wan
Journal:  Mol Med Rep       Date:  2022-08-12       Impact factor: 3.423

9.  Ginseng berry concentrate prevents colon cancer via cell cycle, apoptosis regulation, and inflammation-linked Th17 cell differentiation.

Authors:  C-Z Wang; C Wan; Y Luo; C-F Zhang; Q-H Zhang; L Chen; C W Park; S H Kim; Z Liu; M Lager; M Xu; L Hou; C-S Yuan
Journal:  J Physiol Pharmacol       Date:  2021-08-06       Impact factor: 3.011

10.  The hedgehog pathway suppresses neuropathogenesis in CD4 T cell-driven inflammation.

Authors:  Nail Benallegue; Hania Kebir; Richa Kapoor; Alexis Crockett; Cen Li; Lara Cheslow; Mohamed S Abdel-Hakeem; James Gesualdi; Miles C Miller; E John Wherry; Molly E Church; M Andres Blanco; Jorge I Alvarez
Journal:  Brain       Date:  2021-07-28       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.